BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Bexarotene

CONTRAINDICATION INĀ  PREGNANCY

  • Bexarotene is a member of the retinoid class of drugs that is associated with birth defects in humans.
  • Caused birth defects when administered orally to pregnant rats.
  • Must not be administered to a pregnant woman.

MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA

  • Negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL within one week prior to therapy. Repeat pregnancy test at monthly intervals during therapy
  • Effective contraception used for 1 month prior to initiation of therapy, during therapy and > 1 month after drug discontinued.
  • See full package insert for complete information

Package Inserts

Bexarotene

Updated January 2018